Fact CheckerSign in

NCT05629520Completed

A Neurobiological Model of Anhedonia

Inflammatory, Behavioral and Neural Markers of Anhedonia in Major Depressive Disorder

Source: ClinicalTrials.gov · Last updated 16 Oct 2024

Brief summary (registry, in English)

The purpose of this research study is to better understand anhedonia in Major Depressive Disorder by investigating the reward-related neural and inflammatory correlates.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
31 Oct 2022
Start date
Feb 2020
Primary completion date
Jul 2024
Lead sponsor
Milton S. Hershey Medical Center
Diseases
Depression
NCT number
NCT05629520

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From Feb 2020 to the primary completion date, Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Comorbid illness such as endocrinological illness (e.g. Cushing's disease) rheumatologic illness (e.g., systemic Lupus erythematosus, current treatment with glucocorticoids), and autoimmune diseases (e.g. psoriasis)
  • Daily NSAID or aspirin use and any metallic implant

Other illness

  • Comorbid Bipolar Disorder
  • Substance use disorder in the last 12 months
  • Schizophrenia, and other psychotic disorders

Other

  • Pregnancy
  • Visual/Hearing Impairments that would keep participant from being able to complete tasks

Who the study is looking for

  • Current diagnosis of MDD based on the MINI International Neuropsychiatric Interview (MINI)
  • For treatment resistant depression participants: unsuccessful treatment with at least 2 types or doses of antidepressant medication treatment
  • Right-handed
  • Capacity for informed consent
  • Score a 9 or higher on the MADRS

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Penn State Milton S. Hershey Medical Center
Coordinator of this site? Confirm its status
HersheyUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.